Kintara Therapeutics Inc KTRA:NASDAQ

Last Price$0.57NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/03/21
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$0.58 (8)
Ask (Size)$0.58 (1)
Day Low / HighN/A - N/A
Volume1.1 M

View Wholesale Distributors IndustryPeer Comparison as of 12/03/2021


Kintara Therapeutics Inc ( NASDAQ )

Price: $0.57
Change: -0.06 (8.98%)
Volume: 1.1 M
4:00PM ET 12/03/2021

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A

Read more news Recent News

-- Earnings Flash (KTRA) KINTARA THERAPEUTICS Reports Q1 Loss $-0.25
8:37AM ET 11/15/2021 MT Newswires


Kintara Therapeutics Names Robert E. Hoffman as CEO
11:06AM ET 11/09/2021 MT Newswires

Kintara Therapeutics (KTRA) said Tuesday Chairman Robert E. Hoffman has been appointed as President and CEO to succeed Saiid Zarrabian, who will remain as...

--Aegis Capital Adjusts Price Target on Kintara Therapeutics to $5 From $7, Maintains Buy Rating
11:07AM ET 9/30/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Kintara Therapeutics Closes $15 Million Registered Direct Offering of Common Shares
3:58PM ET 9/28/2021 MT Newswires

Kintara Therapeutics (KTRA) said Tuesday it closed its registered direct offering, priced at-the-market, of 12 million common shares and warrants to buy up...

View all Commentary and Analysis

Kintara Therapeutics (KTRA) Investor Presentation - Slideshow
3:33PM ET 5/21/2021 Seeking Alpha

Company Profile

Business DescriptionKintara Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of new cancer therapies. It focuses on VAL-083 and REM-001 pipelines. The company was founded by Jeffrey A. Bacha, Dennis M. Brown, and William J. Garner on June 24, 2009 and is headquartered in San Diego, CA. View company web site for more details
Address12707 High Bluff Drive
San Diego, California 92130
Number of Employees19
Recent SEC Filing11/24/20214
Chairman, President & Chief Executive OfficerRobert E. Hoffman
Operations HeadGreg A. Johnson
Chief Financial Officer & SecretaryScott Praill
Chief Scientific OfficerDennis M. Brown

Company Highlights

Price Open$0.63
Previous Close$0.63
52 Week Range$0.56 - 3.35
Market Capitalization$27.8 M
Shares Outstanding48.5 M
SectorDistribution Services
IndustryWholesale Distributors
Next Earnings Announcement02/11/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.90
Beta vs. S&P 500N/A
Net Profit MarginN/A
Return on Equity-156.01%

Analyst Ratings as of 09/27/2021

Consensus RecommendationConsensus Icon
Powered by Factset